SCHEMBL30337199

SCHEMBL30337199

Cn1c(-c2ccccc2)c(-c2ccnc(Cl)n2)c2ccccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TEK Q02763 1/20 0.46
ALDH1A1 P00352 4/20 0.43
LMNA P02545 2/20 0.43
HSD17B10 Q99714 2/20 0.42
CYP2C19 P33261 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
MAPT P10636 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
ATM Q13315 1/20 0.41
HPGD P15428 1/20 0.41
CYP11B2 P19099 2/20 0.40
EGFR P00533 1/20 0.40
TERT O14746 1/20 0.40
TLR7 Q9NYK1 1/20 0.36
MAPK14 Q16539 2/20 0.36
KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17384806 1.00 TEK (0.46) TEKALDH1A1LMNAHSD17B10CYP2C19
SCHEMBL21165735 0.89 KMT2A (0.40) TEKLMNAMAPTHTTCYP11B2
SCHEMBL17384819 0.85 EGFR (0.48) TEKMAPTL3MBTL1CYP11B2EGFR
SCHEMBL17822333 0.82 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10CYP2C19SMN1; SMN2
SCHEMBL30337202 0.82 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10CYP2C19SMN1; SMN2
SCHEMBL17385205 0.79 ALDH1A1 (0.44) TEKALDH1A1LMNAHSD17B10CYP2C19
SCHEMBL19103283 0.78 EGFR (0.41) TEKALDH1A1LMNAHSD17B10SMN1; SMN2
SCHEMBL17384807 0.77 EGFR (0.53) L3MBTL1EGFRKMT2A
SCHEMBL822744 0.75 ALDH1A1 (0.59) ALDH1A1LMNAHSD17B10CYP2C19SMN1; SMN2
SCHEMBL19103280 0.74 KDM4E (0.47) ALDH1A1HSD17B10MAPTHPGDEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115974845-B Preparation method of Ornitinib intermediate 奥锐特药业股份有限公司 2024-09-20 CN disclosed
CN-115974845-A Preparation method of oxitinib intermediate 奥锐特药业股份有限公司 2023-04-18 CN disclosed